Research background · Updated November 1, 2026
Sermorelin Research: Publications, Study Types and Background
Short answer
Sermorelin. As of November 1, 2026, PubMed indexes 25 records matching Sermorelin, the earliest from 1990; 9 were published in 2021–2025 and 7 are reviews. ClinicalTrials.gov lists 42 registered studies matching the compound.
- PubMed records
- 25
- Earliest record
- 1990
- Published 2021–2025
- 9
- Reviews
- 7
- Animal-only studies
- 0
- Registered studies
- 42
Publications per year, 2006–2025
14 records in 2016–2025 against 3 in 2006–2015; the busiest year was 2023, with 3.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 1 |
| 2007 | 0 |
| 2008 | 0 |
| 2009 | 0 |
| 2010 | 0 |
| 2011 | 0 |
| 2012 | 0 |
| 2013 | 0 |
| 2014 | 0 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 0 |
| 2019 | 0 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Study types
| All PubMed records | 25 |
|---|---|
| Reviews | 728% |
| Animal studies (no human subjects indexed) | 00% |
| Indexed as clinical trials | 00% |
| Registered on ClinicalTrials.gov | 42 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 1 of the most-cited and most recent Sermorelin papers report, in their own authors’ terms. Each line links the paper it came from.
GHRH analogue and GH testing
This review describes sermorelin as a 29-amino-acid analogue of human growth hormone-releasing hormone and notes that a normal growth hormone response to intravenous sermorelin cannot by itself exclude growth hormone deficiency caused by a hypothalamic deficit.
ReviewPrakash A 1999BioDrugsPMID 18031173
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 25 of the 25 records. They describe what the literature is about, not what Sermorelin does.
- Sermorelin6 papers
- Growth Hormone-Releasing Hormone5 papers
- Doping in Sports5 papers
- Performance-Enhancing Substances4 papers
- Substance Abuse Detection3 papers
- Growth Hormone2 papers
- Tandem Mass Spectrometry2 papers
- Insulin-Like Growth Factor I2 papers
Key papers
Earliest indexed record
de Zegher F (1990). The Journal of clinical endocrinology and metabolism.
PMID 2143200Most-cited paper · 61 citations
Esposito P (2003). Advanced drug delivery reviews.
PMID 14499707Most-cited #2 · 59 citations
de Zegher F (1990). The Journal of clinical endocrinology and metabolism.
PMID 2143200Most-cited #3 · 34 citations
Thomas A (2015). Drug testing and analysis.
PMID 26382721
Citation counts from NIH iCite, among the 25 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| CAS | 86168-78-7 |
|---|---|
| Molecular formula | C149H246N44O42S |
| Molecular weight | 3357.9 g/mol |
| Synonyms | SERMORELIN, Sermorelina, Sermoreline, Sermorelinum, DTXSID70903978 |
Identity data from PubChem, retrieved November 1, 2026, on the Sermorelin page.
How these numbers were counted
- PubMed search, run November 1, 2026:
sermorelin[tiab]re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
sermorelinre-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use Sermorelin outside a laboratory.
Wholesale supply
Sermorelin, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
Sermorelin research questions
How much research has been published on Sermorelin?
PubMed indexes 25 records matching Sermorelin (searched November 1, 2026), including 7 reviews and 0 records indexed as clinical trials. 9 were published in the five years 2021–2025.
When was Sermorelin first described in the literature?
The earliest PubMed record matching Sermorelin is from 1990 (de Zegher F, The Journal of clinical endocrinology and metabolism, PMID 2143200).
What topics does the Sermorelin literature cover?
The subject headings PubMed indexers most often marked as a main topic of Sermorelin papers are Sermorelin, Growth Hormone-Releasing Hormone, Doping in Sports, Performance-Enhancing Substances. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is Sermorelin sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy Sermorelin wholesale for research?
We source Sermorelin to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.